20 results
DEFA14A
APLS
Apellis Pharmaceuticals Inc
26 Apr 24
Additional proxy soliciting materials
4:08pm
public accounting firm for the fiscal year ending December 31, 2024; 3. Approval of an advisory vote on executive compensation; and 4. Transaction
DEFA14A
APLS
Apellis Pharmaceuticals Inc
21 Apr 23
Additional proxy soliciting materials
9:03am
independent registered public accounting firm for the fiscal year ending December 31, 2023. 3. To approve an advisory vote on executive compensation
DEFA14A
APLS
Apellis Pharmaceuticals Inc
20 Apr 22
Additional proxy soliciting materials
4:09pm
vote on executive compensation. THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR ON PROPOSALS 1, 2 AND 3
DEFA14A
7hhu zj2g2
22 Apr 21
Additional proxy soliciting materials
4:08pm
8-K
cta4k05219m7
21 Jun 19
Submission of Matters to a Vote of Security Holders
4:15pm
DEFA14A
rhzga4m nj
30 Apr 19
Additional proxy soliciting materials
8:02am
10-K
us875v98hlbr bmr
19 Mar 18
Annual report
12:00am
10-Q
nzbp6m6 y0rdhxptqei
20 Dec 17
Quarterly report
12:00am
- Prev
- 1
- Next